HIV drug resistance and risk factors associated with first-line regimen failure in Maputo and Tete, Mozambique

Principal investigator

Petros Isaakidis
Purpose of study
Purpose of study

The global scale-up of antiretroviral therapy has led to a growing number of people under treatment, notably in sub-Saharan Africa. Despite good short-term health outcomes, antiretroviral therapy (ART) roll-out is accelerating the number of pati...

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline


  • High level of HIV drug resistance informs dolutegravir roll-out and optimized NRTI backbone strategy in Mozambique
    Carnimeo, V "–" Oxford University Press (OUP) "(2021)"
Previous study
Next study